VXM01 Plus Avelumab Combination Study in Progressive Glioblastoma

Clinical trial NCT03750071 · UNKNOWN

Trial details

NCT number: NCT03750071
Sponsor: Vaximm GmbH
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent Glioblastoma

Start date: 2018-11-21
Primary completion: 2021-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.